Park Medi World Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Strong return on equity (ROE 16.7%)
- ✓Efficient capital deployment (ROCE 19.3%)
- ✓Low debt relative to equity (D/E 0.2x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Latest News
All news →Park Medi World hosts analyst and institutional investor meet
*Park Medi World hosts analyst and institutional investor meet* to discuss business updates and strategy. The company shared insights during the scheduled investor call. No major financial announcements or guidance changes were disclosed. Such meets are routine for market transparency. 📊 *STOCKS:* PARKHOTEL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #AnalystMeet
Park Medi World to host analyst and investor meet.
*Park Medi World to host analyst and investor meet.* The company has scheduled a con-call for analysts and institutional investors. Details are available in the NSE corporate filing. No financial updates or major announcements were disclosed. 📊 *STOCKS:* PARKHOSP | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #InvestorMeet
Park Medi World buys The Medicity Hospital for ₹177 crore
*Park Medi World buys The Medicity Hospital for ₹177 crore* — Park Medi World has announced the acquisition of The Medicity Hospital in Rudrapur for **₹177 crore**, expanding its healthcare footprint. The move strengthens its presence in tier-2 cities and adds significant bed capacity. The deal is expected to be accretive to long-term growth. 📊 *STOCKS:* PARKHOSP | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Hospital_Acquisition
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Revenue | ₹460 Cr ▲12.2% | ₹410 Cr ▲0.0% | ₹410 Cr ▲15.8% | ₹354 Cr ▲1.7% | ₹348 Cr |
| Op. Profit | ₹127 Cr ▲28.3% | ₹99 Cr ▼12.4% | ₹113 Cr ▲28.4% | ₹88 Cr ▲6.0% | ₹83 Cr |
| OPM | 28.0% ▲16.7% | 24.0% ▼11.1% | 27.0% ▲8.0% | 25.0% ▲4.2% | 24.0% |
| Net Profit | ₹77 Cr ▲45.3% | ₹53 Cr ▼32.9% | ₹79 Cr ▲51.9% | ₹52 Cr ▲13.0% | ₹46 Cr |
| EPS (₹) | 1.64 ▲40.2% | 1.17 ▼38.7% | 1.91 ▲63.2% | 1.17 ▼60.6% | 2.97 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue | ₹1.7K Cr ▲20.4% | ₹1.4K Cr ▲13.2% | ₹1.2K Cr ▼1.9% | ₹1.3K Cr ▲15.8% | ₹1.1K Cr ▲41.5% | ₹766 Cr |
| Expenses | ₹1.2K Cr ▲21.3% | ₹1.0K Cr ▲10.8% | ₹919 Cr ▲6.5% | ₹863 Cr ▲16.6% | ₹740 Cr ▲61.9% | ₹457 Cr |
| Op. Profit | ₹444 Cr ▲18.4% | ₹375 Cr ▲20.2% | ₹312 Cr ▼20.2% | ₹391 Cr ▲13.3% | ₹345 Cr ▲11.7% | ₹309 Cr |
| OPM | 26.0% ▼3.7% | 27.0% ▲8.0% | 25.0% ▼19.4% | 31.0% ▼3.1% | 32.0% ▼20.0% | 40.0% |
| Other Income | ₹32 Cr ▲6.7% | ₹30 Cr ▲3.4% | ₹29 Cr ▲93.3% | ₹15 Cr ▲66.7% | ₹9 Cr ▲200.0% | ₹3 Cr |
| Interest | ₹59 Cr ▼3.3% | ₹61 Cr ▼15.3% | ₹72 Cr ▲41.2% | ₹51 Cr ▲27.5% | ₹40 Cr ▲66.7% | ₹24 Cr |
| Depreciation | ₹62 Cr ▲6.9% | ₹58 Cr ▲13.7% | ₹51 Cr ▲24.4% | ₹41 Cr ▲17.1% | ₹35 Cr ▲45.8% | ₹24 Cr |
| PBT | ₹355 Cr ▲23.7% | ₹287 Cr ▲31.7% | ₹218 Cr ▼30.8% | ₹315 Cr ▲13.3% | ₹278 Cr ▲4.9% | ₹265 Cr |
| Tax % | 23.0% ▼11.5% | 26.0% ▼13.3% | 30.0% ▲7.1% | 28.0% ▲0.0% | 28.0% ▲7.7% | 26.0% |
| Net Profit | ₹274 Cr ▲28.6% | ₹213 Cr ▲40.1% | ₹152 Cr ▼33.3% | ₹228 Cr ▲14.6% | ₹199 Cr ▲6.4% | ₹187 Cr |
| EPS (₹) | 5.98 ▲12.0% | 5.34 ▼46.5% | 9.98 ▼30.2% | 14.29 ▲21.5% | 11.76 ▼85.4% | 80.54 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Liabilities | ||||||
| Equity Capital | ₹86 Cr ▲11.7% | ₹77 Cr ▲0.0% | ₹77 Cr ▲0.0% | ₹77 Cr ▲0.0% | ₹77 Cr ▲305.3% | ₹19 Cr |
| Reserves | ₹1.9K Cr ▲95.0% | ₹993 Cr ▲23.2% | ₹806 Cr ▲32.1% | ₹610 Cr ▲60.5% | ₹380 Cr ▲48.4% | ₹256 Cr |
| Borrowings | ₹364 Cr ▼46.6% | ₹682 Cr ▼0.7% | ₹687 Cr ▲19.3% | ₹576 Cr ▲11.4% | ₹517 Cr ▲77.1% | ₹292 Cr |
| Other Liabilities | ₹427 Cr ▲11.8% | ₹382 Cr ▲11.4% | ₹343 Cr ▲3.6% | ₹331 Cr ▲3.8% | ₹319 Cr ▲28.1% | ₹249 Cr |
| Total Liabilities | ₹2.8K Cr ▲31.8% | ₹2.1K Cr ▲11.6% | ₹1.9K Cr ▲20.0% | ₹1.6K Cr ▲23.2% | ₹1.3K Cr ▲58.5% | ₹816 Cr |
| Assets | ||||||
| Fixed Assets | ₹1.3K Cr ▲45.8% | ₹898 Cr ▲7.3% | ₹837 Cr ▲56.2% | ₹536 Cr ▲17.0% | ₹458 Cr ▲25.5% | ₹365 Cr |
| CWIP | ₹123 Cr ▲232.4% | ₹37 Cr ▲15.6% | ₹32 Cr ▲540.0% | ₹5 Cr ▼82.8% | ₹29 Cr ▲314.3% | ₹7 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹1.4K Cr ▲15.2% | ₹1.2K Cr ▲15.0% | ₹1.0K Cr ▼0.9% | ₹1.1K Cr ▲30.5% | ₹806 Cr ▲81.9% | ₹443 Cr |
| Total Assets | ₹2.8K Cr ▲31.8% | ₹2.1K Cr ▲11.6% | ₹1.9K Cr ▲20.0% | ₹1.6K Cr ▲23.2% | ₹1.3K Cr ▲58.5% | ₹816 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Operating CF | ₹329 Cr ▲72.3% | ₹191 Cr ▼48.0% | ₹367 Cr ▲84.4% | ₹199 Cr ▲28.4% | ₹155 Cr ▼30.5% | ₹223 Cr |
| Investing CF | ₹-333 Cr ▼265.9% | ₹-91 Cr ▼19.7% | ₹-76 Cr ▲67.5% | ₹-234 Cr ▲5.6% | ₹-248 Cr ▼6.4% | ₹-233 Cr |
| Financing CF | ₹121 Cr ▲263.5% | ₹-74 Cr ▲43.1% | ₹-130 Cr ▼13100.0% | ₹1 Cr ▼99.4% | ₹163 Cr ▲232.7% | ₹49 Cr |
| Net Cash Flow | ₹116 Cr ▲346.2% | ₹26 Cr ▼83.9% | ₹161 Cr ▲573.5% | ₹-34 Cr ▼148.6% | ₹70 Cr ▲79.5% | ₹39 Cr |
| Free Cash Flow | ₹209 Cr ▲216.7% | ₹66 Cr ▼77.9% | ₹299 Cr ▲182.1% | ₹106 Cr ▲65.6% | ₹64 Cr ▼25.6% | ₹86 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Debtor Days | 129d ▼19.9% | 161d ▲6.6% | 151d ▼10.1% | 168d ▲11.3% | 151d ▲0.0% | 151d |
| Inventory Days | 4d | — | 3d ▲0.0% | 3d ▼78.6% | 14d ▼70.2% | 47d |
| Days Payable | 134d | — | 133d ▲20.9% | 110d ▲8.9% | 101d ▼16.5% | 121d |
| Cash Conv. Cycle | -2d ▼101.2% | 161d ▲666.7% | 21d ▼65.6% | 61d ▼4.7% | 64d ▼16.9% | 77d |
| Working Capital Days | 28d ▼9.7% | 31d ▲47.6% | 21d ▼47.5% | 40d ▼33.3% | 60d ▲50.0% | 40d |
| ROCE | 19.0% ▼5.0% | 20.0% ▲0.0% | 20.0% ▼35.5% | 31.0% ▼18.4% | 38.0% | — |
Source: Screener.in · Lower days = better efficiency